BGB-3111-214

Active, not recruiting

Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma

Beigene Study ID info

BGB-3111-214

ClinicalTrials.gov ID info

EudraCT Number info

2018-001284-24

Clinical Drug Trials ID info

CTR20180823

Study Overview

Sex: All

Age: 18 Years and older (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents

Study Overview

Sex: All

Age: 18 Years and older (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents